v3.26.1
Note 13 - Stock Based Compensation
6 Months Ended
Jun. 30, 2026
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

Note 13 Stock Based Compensation

 

The Company’s 2017 Omnibus Stock Plan (2017 OSP) was adopted by the Company’s BOD on February 24, 2017, and approved by the Company’s shareholders at the May 25, 2017, Annual Meeting of Shareholders. The 2017 OSP enables the Company to grant stock incentive awards to current and new employees, including officers, and to BOD members and service providers. The 2017 OSP permits stock incentive awards in the form of Options (incentive and non-qualified), stock appreciation rights, restricted stock, restricted stock units, performance stock, performance units, and other awards in stock or cash. The 2017 OSP permits the issuance of up to 625,000 shares of our Common Stock in any of the above stock awards. As of June 30, 2026, 20,582 shares remain available for future grants under the 2017 OSP.

 

Option Awards

 

Prior to 2025, the Compensation Committee granted non-qualified stock Options. The Compensation Committee believed that grants of Options more directly aligned management’s long-term equity compensation with increased shareholder value creation at a time when the Company is engaged in significant investment and transformation as part of its long-term strategy. The Compensation Committee also determined to extend the grant of Options to include Named Executive Officers, senior employee directors and other employee directors as key members of the Company leadership team and contributors to our overall success.

 

The following table summarizes the Company’s exercisable employee stock Option activity under the 2017 OSP, which was approved by the Company’s shareholders, for the following periods:

 

                   

Weighted

         
   

Number of

   

Weighted

   

Average

   

Aggregate

 
   

Shares

   

Average

   

Remaining

   

Intrinsic

 
   

Excercisable

   

Exercise Price

   

Term (Years)

   

Value

 

Outstanding as of December 31, 2021

    -     $ -       -     $ -  

Granted

    121,743       21.20       5.78       -  

Forfeited

    -       -       -       -  

Outstanding as of December 31, 2022

    121,743     $ 21.20       5.78     $ -  

Granted

    154,294       14.70       6.75       401,164  

Forfeited

    -       -       -       -  

Outstanding as of December 31, 2023

    276,037     $ 17.57       6.33     $ 401,164  

Granted

    107,453       11.00       7.75       676,954  

Forfeited

    -       -       -       -  

Outstanding as of December 31, 2024

    383,490     $ 15.73       6.69     $ 1,078,118  

Granted

    -       -       -       -  

Forfeited

    (27,482 )     13.60       -       (121,926 )

Outstanding as of December 31, 2025

    356,008     $ 16.96       6.69     $ 956,192  

Granted

    -       -       -       -  

Forfeited

    -       -       -       -  

Outstanding as of June 30, 2026

    356,008     $ 16.96       6.69     $ 956,192  

Exercisable as of June 30, 2026

    326,946     $ 17.31       6.59     $ 773,102  

 

The weighted average grant date fair value per share for employee stock and non-employee Option grants issued on March 28, 2024, was $4.34. The weighted average grant date fair value per share for employee stock and non-employee stock Option grants issued on March 31, 2023, was $2.90. The weighted average grant date fair value per share for employee stock and non-employee Option grants issued on April 11, 2022, was $3.24. As of June 30, 2026, the total unrecognized compensation related to unvested employee and non-employee stock Option awards granted was $94,681, which the Company expects to recognize over a weighted-average period of approximately 0.73 years. As of December 31, 2025, the total unrecognized compensation related to unvested employee and non-employee stock Option awards granted was $187,017, which the Company expects to recognize over a weighted-average period of approximately 1.07 years.